Company / SG&A per Share
Xenetic Biosciences, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.22
FY2025
5-year range
$0.28 / $2.41
FY2021-FY2025
Trend
-4.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $0.28 in FY2022 to $2.41 in FY2023.
Based on SEC 10-K filings.
2.22 in FY2025 with a 5-year CAGR of +23.2%.
Improved from $2.41 to $2.22 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +99.6%
- 5-Year CAGR
- +23.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 4.2% year-over-year.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.22 | -4.2% |
| FY2024 | $2.31 | -4.1% |
| FY2023 | $2.41 | +764.8% |
| FY2022 | $0.28 | -28.3% |
| FY2021 | $0.39 | -50.2% |
| FY2020 | $0.78 | +7.7% |
| FY2019 | $0.72 | -9.0% |
| FY2018 | $0.80 | -45.5% |
| FY2017 | $1.46 | +4.8% |
| FY2016 | $1.39 | +2483.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026